Mereo BioPharma Group plc American Depositary Shares (NASDAQ: MREO) last traded at $0.290, down 0.99% on the session. The quote above updates while this page is open; the figures below are drawn from Mereo BioPharma Group plc American Depositary Shares’s own filings and are restated only when a new one is published.
Mereo BioPharma Group plc American Depositary Shares trades on NASDAQ under the ticker MREO. Its market capitalisation is $231.87 million.
Valuation measures for Mereo BioPharma Group plc American Depositary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $231.87M |
|---|---|
| Enterprise value | $207.82M |
| Price / sales | 463.74 |
| Price / book | 8.09 |
| Beta | 1.49 |
Trailing-twelve-month figures tagged in Mereo BioPharma Group plc American Depositary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $500.0K |
|---|---|
| Net income (TTM) | -$28.10M |
| EPS (TTM) | -$0.0300 |
| Operating margin | -6840.40% |
| Return on equity | -98.07% |
| Cash | $30.12M |
Range and volume for MREO over the past 52 weeks.
| 52-week high | $2.37 |
|---|---|
| 52-week low | $0.200 |
| Volume | 688.0K |
| Average volume | 5.71M |
| Previous close | $0.293 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.